# Blue Owl's Biotech Investments: 14 Startups in Its Portfolio (2026) > The 14 Biotech startups Blue Owl has backed, by stage: $4.0B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/blue-owl-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 5 - [BridgeBio](https://millionrounds.com/company/bridgebio) - [Palvella Therapeutics](https://millionrounds.com/company/palvella-therapeutics) - [Pyxis Oncology](https://millionrounds.com/company/pyxis-oncology) - [Context Therapeutics](https://millionrounds.com/company/context-therapeutics) - [Korro Bio](https://millionrounds.com/company/korro-bio) ## Series C and later 5 - [Star Therapeutics](https://millionrounds.com/company/star-therapeutics) - [Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics) - [Aviceda Therapeutics](https://millionrounds.com/company/aviceda-therapeutics) - [Electra Therapeutics](https://millionrounds.com/company/electra-therapeutics) - [Lycia Therapeutics](https://millionrounds.com/company/lycia-therapeutics) ## Series B 4 - [Windward Bio](https://millionrounds.com/company/windward-bio) - [Cardurion Pharmaceuticals](https://millionrounds.com/company/cardurion-pharmaceuticals) - [Mirador Therapeutics](https://millionrounds.com/company/mirador-therapeutics) - [Syros Pharmaceuticals](https://millionrounds.com/company/syros-pharmaceuticals) ## Segment by segment ### Stage not reported 5 startups · $1.9B raised - [**BridgeBio**](https://millionrounds.com/company/bridgebio) BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers. United States $1.4B - [**Palvella Therapeutics**](https://millionrounds.com/company/palvella-therapeutics) Palvella Therapeutics is a clinical-stage biopharmaceutical company based in Wayne, Pennsylvania. United States $210M - [**Pyxis Oncology**](https://millionrounds.com/company/pyxis-oncology) Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer. United States $110M - [**Context Therapeutics**](https://millionrounds.com/company/context-therapeutics) Context Therapeutics is a clinical-stage biopharmaceutical company. United States $100M - [**Korro Bio**](https://millionrounds.com/company/korro-bio) Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. United States $85M ### Series C and later 5 startups · $1.1B raised - [**Star Therapeutics**](https://millionrounds.com/company/star-therapeutics) Star Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018. United States $325M - [**Obsidian Therapeutics**](https://millionrounds.com/company/obsidian-therapeutics) Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy. United States $210M - [**Aviceda Therapeutics**](https://millionrounds.com/company/aviceda-therapeutics) Aviceda Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2018. United States $208M - [**Electra Therapeutics**](https://millionrounds.com/company/electra-therapeutics) Electra Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018. United States $183M - [**Lycia Therapeutics**](https://millionrounds.com/company/lycia-therapeutics) Lycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California. United States $182M ### Series B 4 startups · $1.0B raised - [**Windward Bio**](https://millionrounds.com/company/windward-bio) Windward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committed Switzerland $365M - [**Cardurion Pharmaceuticals**](https://millionrounds.com/company/cardurion-pharmaceuticals) Cardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeutics United States $260M - [**Mirador Therapeutics**](https://millionrounds.com/company/mirador-therapeutics) Mirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California. United States $250M - [**Syros Pharmaceuticals**](https://millionrounds.com/company/syros-pharmaceuticals) Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits. United States $128M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Blue Owl as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Blue Owl** 57 co-investors](https://millionrounds.com/portfolio-maps/blue-owl-co-investors)[Portfolio map **Blue Owl portfolio map** 38 startups · $71B](https://millionrounds.com/portfolio-maps/blue-owl-portfolio-map)[Sector portfolio **Perceptive Advisors' Biotech portfolio** 101 startups · $24B](https://millionrounds.com/portfolio-maps/perceptive-advisors-biotech-portfolio)[Sector portfolio **BlackRock's AI portfolio** 41 startups · $529B](https://millionrounds.com/portfolio-maps/blackrock-ai-portfolio)[Sector portfolio **BlackRock's Fintech portfolio** 25 startups · $17B](https://millionrounds.com/portfolio-maps/blackrock-fintech-portfolio)[Sector portfolio **BlackRock's Biotech portfolio** 19 startups · $4.2B](https://millionrounds.com/portfolio-maps/blackrock-biotech-portfolio) ## Raising from investors like Blue Owl? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)